December 19, 2013

Press Release No. 1

Clarification by Dishman Pharmaceuticals and Chemicals Limited

Substantial increase in trading volumes have been observed in Dishman Pharmaceuticals and Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dishman Pharmaceuticals and Chemicals Limited has vide its letter inter-alia stated, "We would like to state that to the best of our knowledge and belief, there is no price sensitive information / development which can have a bearing on the performances of the Company and which has not been announced by the Company."

Press Release No. 2

Market-wide Position Limit in APOLLOTYRE

The derivative contracts in the underlying APOLLOTYRE have crossed 95% of the market-wide position limit on Dec 19, 2013. It is hereby informed that all clients/ members shall trade in derivative contracts of APOLLOTYRE by offsetting their existing positions till the open interest comes down to 80% of the market wide position limit.